Ascendis Health Limited

ASC

ZAE000185005

Pharmaceuticals

End-of-day quote Johannesburg S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
0.79 ^ZAR	-.--%		-2.47%	+1.28%

29/03	Ascendis Health Seeks Acquisitions	CI
28/03	Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Ascendis Health Limited Appoints Harry Smit as Chairman to the Board, Effective January 13, 2022

January 13, 2022 at 07:43 pm IST

Ascendis Health Limited announced that Mr. Harry Smit, a current independent non-executive director of the Company, has been appointed as Chairman to the Board with effect from 13 January 2022.

Latest news about Ascendis Health Limited

Ascendis Health Seeks Acquisitions	29/03	CI
Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/03	CI
Ascendis Health Limited Provides Earnings Guidance for the Six Months Ended 31 December 2023	26/03	CI
Ascendis Health Limited Announces Board Changes	25/03	CI
Ascendis Health Limited Announces Lawrence Mulaudzi Not Available for Re-Election as Director	30/11	CI
Ascendis Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29/23/29	CI
Ascendis Health Limited Appoints Joseph Fine as Company Secretary	27/23/27	CI
Ascendis Health Flags Drop in FY23 EPS	26/23/26	MT
Ascendis Health Limited Provides Earnings Guidance for the Year Ended 30 June 2023	26/23/26	CI
Ascendis Health Advances Cost-cutting Program With New Auditor	06/23/06	MT
Ascendis Health Books Lower Fiscal H1 Attributable Profit	27/23/27	MT
Ascendis Health Terminates PricewaterhouseCoopers as Auditor	20/23/20	MT
South African Stocks End Tumultuous Week in the Red	17/23/17	MT
Ascendis Health Flags Lower EPS in Fiscal H1	17/23/17	MT
Ascendis Health Limited Appoints Bharti Harie as Chairman of the Board	09/22/09	CI
Ascendis Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022	28/22/28	CI
Ascendis Health Limited Reports Earnings Results for the Full Year Ended June 30, 2022	28/22/28	CI
Transcript : Ascendis Health Limited, 2022 Earnings Call, Sep 28, 2022	28/22/28
Ascendis Health Limited Auditor Raises 'Going Concern' Doubt	27/22/27	CI
Ascendis Health Limited Announces Resignation of Richard Dawes an Independent Non-Executive Director	28/22/28	CI
Pharma-Q Holdings Ltd. and Imperial Logistics Limited cancelled the acquisition of Medicine Developers International/Pharmachem Pharmaceuticals/Alliance Pharma/Ascendis Pharma from Ascendis Health Limited.	27/22/27	CI
Ascendis Health Limited Announces Board Changes	13/22/13	CI
Ascendis Health Limited Announces Resignation of Gary Shayne as A Non-Executive Director	06/22/06	CI
Ascendis Health Limited Appoints Riyas Fadal as Chief Operating Officer	04/22/04	CI
Ascendis Health Seeks Acquisitions	19/22/19	CI

Ascendis Health Limited specializes in developing, manufacturing and marketing care and health products. Net sales break down by family of products as follows: - pharmaceutical products (61.3%): primarily prescription drugs. The group also provides medical devices used in the radiology and surgery fields; - consumer products (31%): OTC medicines, vitamins and minerals, homeopathic products, ayurvedic products, sports nutrition products, functional foods, etc.; - care products for plants and animals (7.7%). Net sales are distributed geographically as follows: South Africa (71.3%), Cyprus (16%) and Romania (12.7%).

Sector

Pharmaceuticals

Calendar

26/09/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASCENDIS HEALTH LIMITED	+1.28%	26.28M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals